Hypnosis to improve sleep in menopause: Determination of optimal dose and method
催眠改善更年期睡眠:最佳剂量和方法的确定
基本信息
- 批准号:9055646
- 负责人:
- 金额:$ 21.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdverse effectsAdverse eventAffectAgeAmericanCardiovascular DiseasesClinical TrialsCollaborationsDataDiabetes MellitusDoseDropoutEmergency department visitEndogenous FactorsEnrollmentEnvironmentEthnic OriginExogenous FactorsGoalsHealthHealthcareHome environmentHot flushesHourHuman ResourcesHypnosisInterventionKnowledgeLaboratoriesLifeLinkMeasurementMeasuresMenopausal StatusMenopausal SymptomMenopauseMethodsMorbidity - disease rateNational Center for Complementary and Alternative MedicinePainParticipantPatient Self-ReportPharmaceutical PreparationsPostmenopausePrevalenceProductivityPublic HealthQuality of lifeQuestionnairesRaceRandomized Clinical TrialsRandomized Controlled TrialsRecording of previous eventsReportingResearchResearch DesignRiskSeveritiesSiteSleepSleep DisordersSleep disturbancesSleeplessnessSocioeconomic StatusStagingStatistical Data InterpretationSymptomsTestingTreatment ProtocolsWomanWorkWristactigraphyalternative treatmentdesigndiarieshormone therapyimprovedinnovationmalignant breast neoplasmmiddle agemortalityobesity riskpost interventionprimary outcomeprogramspublic health relevancesatisfactionsecondary outcomestatisticssuccesstrend
项目摘要
DESCRIPTION (provided by applicant): Poor sleep is among the most frequent, yet least addressed, health concern among women during the menopause transition and the prevalence of poor sleep increases with age. In addition, poor sleep has been associated with increased risks for other health problems, adverse effects of prescription sleep medications, and mortality; affecting the quality of life and health of midlife women. Our laboratory has identified that hypnosis, when delivered with five (5), therapist delivered, individualized hypnosis inductions can improve self- reported sleep quality among postmenopausal women presenting with a primary complaint of hot flashes. However, as currently developed, hypnosis is labor intensive and not easily disseminable, thus, limiting its potential public health impact. If a hypnosis program could be developed that is less personnel-intensive and more easily disseminable, it could have a large public health impact on the sleep of midlife women. In addition, the potential impact of any hypnosis program on objectively measured sleep has not yet been examined and there is little data for effect size estimates. Our long range goal is to identify a safe, efficacius, and widely disseminable hypnosis intervention for the treatment of sleep problems during the menopause transition. The purpose of this application is to determine the optimal dose and delivery method for a hypnosis program that shows feasibility, acceptable adherence, and preliminary effects on sleep (primary outcomes) and other secondary outcomes (sleep quality, insomnia symptom severity, daytime sleepiness, menopausal symptoms, and pain). We will enroll 80 menopausal women into a 2X2 factorial design to compare two dosing (three vs. five sessions) and two delivery methods of hypnosis (audio recorded vs. therapist delivered inductions) with assessments at baseline and four, six, and eight weeks post-intervention. Specific aims are to (1) Determine the feasibility of and adherence to the four hypnosis programs; (2) Determine initial effect sizes for the primary outcome of objectively measured sleep duration, including the percent of women who achieve a clinically meaningful improvement; (3) Determine initial effect sizes for secondary outcomes of sleep quality, insomnia symptom severity, daytime sleepiness, menopausal symptoms, and pain; and (4) Trends in potential covariates including endogenous factors (e.g., age, race/ethnicity, menopausal stage) and exogenous factors (e.g., sleep environment, socioeconomic status). Statistical analysis will determine feasibility (< 25% dropout; rating of "good" or better for the program, and <5% adverse events) and adherence (> 75% compliance with daily at-home practice). Estimated effect sizes for primary and secondary outcomes will be calculated using standard methods and the optimal programs identified (e.g., a >b>c>d). Trends in potential covariates will be analyzed using Pearson correlations for continuous covariates (e.g., age), and for categorical covariates (e.g., demographic/environment variables) t tests or ANOVAs will be conducted, as appropriate. Findings will provide the requisite data to plan a subsequent R01 application for a multi-site, large-scale, randomized controlled trial.
描述(由申请人提供):睡眠不佳是绝经过渡期妇女最常见但最不受关注的健康问题之一,睡眠不佳的患病率随着年龄的增长而增加。此外,睡眠不佳与其他健康问题的风险增加,处方睡眠药物的不良影响和死亡率有关;影响中年妇女的生活质量和健康。我们的实验室已经确定,催眠,当提供五(5),治疗师提供,个性化的催眠诱导可以改善自我报告的睡眠质量绝经后妇女提出的主要投诉潮热。然而,就目前的发展而言,催眠是劳动密集型的,不容易传播,因此限制了其潜在的公共卫生影响。如果能够开发出一种人员密集度更低、更容易传播的催眠程序,它可能会对中年妇女的睡眠产生巨大的公共卫生影响。此外,任何催眠程序对客观测量的睡眠的潜在影响尚未被研究,并且几乎没有数据用于估计效应大小。我们的长期目标是确定一种安全,有效,广泛传播的催眠干预治疗更年期过渡期的睡眠问题。本申请的目的是确定催眠程序的最佳剂量和递送方法,该催眠程序显示可行性、可接受的依从性以及对睡眠(主要结局)和其他次要结局(睡眠质量、失眠症状严重程度、白天嗜睡、更年期症状和疼痛)的初步影响。我们将招募80名绝经期女性进入2X2析因设计,以比较两种剂量(三次与五次)和两种催眠方法(录音与治疗师提供的诱导),并在基线和干预后4周,6周和8周进行评估。具体目标是:(1)确定四种催眠方案的可行性和依从性;(2)确定客观测量的睡眠持续时间的主要结局的初始效应量,包括实现临床有意义改善的妇女的百分比;(3)确定睡眠质量、失眠症状严重程度、白天嗜睡、更年期症状和疼痛的次要结局的初始效应量;和(4)潜在协变量的趋势,包括内源性因素(例如,年龄、种族/民族、绝经阶段)和外源性因素(例如,睡眠环境、社会经济状况)。统计分析将确定可行性(< 25%的脱落率;该计划的“良好”或更好的评级,以及<5%的不良事件)和依从性(> 75%的日常在家实践依从性)。主要和次要结局的估计效应量将使用标准方法和确定的最佳程序(例如,a >B>c>d)。对于连续协变量,将使用Pearson相关性分析潜在协变量的趋势(例如,年龄),以及分类协变量(例如,人口统计学/环境变量)t检验或方差分析。研究结果将提供必要的数据,以计划随后的R 01应用于多中心,大规模,随机对照试验。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hypnosis Intervention for Sleep Disturbance: Determination of Optimal Dose and Method of Delivery for Postmenopausal Women.
睡眠障碍的催眠干预:确定绝经后妇女的最佳剂量和分娩方法。
- DOI:10.1080/00207144.2021.1919520
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Elkins,Gary;Otte,Julie;Carpenter,JanetS;Roberts,Lynae;Jackson,Lea'S;Kekecs,Zoltan;Patterson,Vicki;Keith,TimothyZ
- 通讯作者:Keith,TimothyZ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gary R Elkins其他文献
Characteristics of Users of a Digital Hypnotherapy Intervention for Hot Flashes: Retrospective Study
潮热数字催眠治疗干预的使用者特征:回顾性研究
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:2.2
- 作者:
Morgan Snyder;Gary R Elkins - 通讯作者:
Gary R Elkins
Gary R Elkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gary R Elkins', 18)}}的其他基金
Hypnosis to improve sleep in menopause: Determination of optimal dose and method
催眠改善更年期睡眠:最佳剂量和方法的确定
- 批准号:
8851523 - 财政年份:2014
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
- 批准号:
8060508 - 财政年份:2007
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
- 批准号:
7503456 - 财政年份:2007
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
- 批准号:
7260831 - 财政年份:2007
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
- 批准号:
7640733 - 财政年份:2007
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes: A Randomized Clinical Trial
催眠治疗潮热:一项随机临床试验
- 批准号:
7807020 - 财政年份:2007
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes in Breast Cancer Survivors
催眠治疗乳腺癌幸存者潮热
- 批准号:
7097753 - 财政年份:2005
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes in Breast Cancer Survivors
催眠治疗乳腺癌幸存者潮热
- 批准号:
6881164 - 财政年份:2004
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes in Breast Cancer Survivors
催眠治疗乳腺癌幸存者潮热
- 批准号:
6718008 - 财政年份:2004
- 资助金额:
$ 21.53万 - 项目类别:
Hypnosis for Hot Flashes in Breast Cancer Survivors
催眠治疗乳腺癌幸存者潮热
- 批准号:
7107475 - 财政年份:2004
- 资助金额:
$ 21.53万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Fellowship Programs














{{item.name}}会员




